talotrexin has been researched along with 4-aminobenzoic acid in 1 studies
| Studies (talotrexin) | Trials (talotrexin) | Recent Studies (post-2010) (talotrexin) | Studies (4-aminobenzoic acid) | Trials (4-aminobenzoic acid) | Recent Studies (post-2010) (4-aminobenzoic acid) |
|---|---|---|---|---|---|
| 27 | 0 | 4 | 2,698 | 55 | 302 |
| Protein | Taxonomy | talotrexin (IC50) | 4-aminobenzoic acid (IC50) |
|---|---|---|---|
| Polyphenol oxidase 2 | Agaricus bisporus | 3.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forsch, RA; Rosowsky, A; Vaidya, CM; Wright, JE | 1 |
1 other study(ies) available for talotrexin and 4-aminobenzoic acid
| Article | Year |
|---|---|
The effect of side-chain, para-aminobenzoyl region, and B-ring modifications on dihydrofolate reductase binding, influx via the reduced folate carrier, and cytotoxicity of the potent nonpolyglutamatable antifolate N(alpha)-(4-amino-4-deoxypteroyl)-N(delta
Topics: 4-Aminobenzoic Acid; Aminopterin; Antineoplastic Agents; Binding Sites; Cell Division; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Folic Acid; Folic Acid Antagonists; Humans; Ornithine; Pterins; Reducing Agents; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Tumor Cells, Cultured | 2000 |